A Phase 1, Open-label Positron Emission Tomography Trial to Assess Changes in Liver Uptake of [68Ga]Ga-FAPI-46 Following Oral Administration of Single Doses of AZD2389 to Patients With Advanced Liver Fibrosis (PECHORA).
Latest Information Update: 30 Jul 2025
At a glance
- Drugs AZD 2389 (Primary)
- Indications Hepatic fibrosis
- Focus Pharmacodynamics
- Acronyms PECHORA
- Sponsors AstraZeneca
Most Recent Events
- 30 Jul 2025 New trial record